151 related articles for article (PubMed ID: 18007520)
21. Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cells.
Sasagawa M; Cech NB; Gray DE; Elmer GW; Wenner CA
Int Immunopharmacol; 2006 Jul; 6(7):1214-21. PubMed ID: 16714226
[TBL] [Abstract][Full Text] [Related]
22. Comparison of alkylamide yield in ethanolic extracts prepared from fresh versus dry Echinacea purpurea utilizing HPLC-ESI-MS.
Spelman K; Wetschler MH; Cech NB
J Pharm Biomed Anal; 2009 Jul; 49(5):1141-9. PubMed ID: 19321283
[TBL] [Abstract][Full Text] [Related]
23. Cytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomes.
Matthias A; Gillam EM; Penman KG; Matovic NJ; Bone KM; De Voss JJ; Lehmann RP
Chem Biol Interact; 2005 Jun; 155(1-2):62-70. PubMed ID: 15885678
[TBL] [Abstract][Full Text] [Related]
24. Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways.
Gertsch J; Schoop R; Kuenzle U; Suter A
FEBS Lett; 2004 Nov; 577(3):563-9. PubMed ID: 15556647
[TBL] [Abstract][Full Text] [Related]
25. Changes in immunomodulatory properties of Echinacea spp. root infusions and tinctures stored at 4 degrees C for four days.
Senchina DS; McCann DA; Asp JM; Johnson JA; Cunnick JE; Kaiser MS; Kohut ML
Clin Chim Acta; 2005 May; 355(1-2):67-82. PubMed ID: 15820480
[TBL] [Abstract][Full Text] [Related]
26. Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer model.
Matthias A; Blanchfield JT; Penman KG; Toth I; Lang CS; De Voss JJ; Lehmann RP
J Clin Pharm Ther; 2004 Feb; 29(1):7-13. PubMed ID: 14748892
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Echinacea alkylamide pharmacokinetics between liquid and tablet preparations.
Matthias A; Addison RS; Agnew LL; Bone KM; Watson K; Lehmann RP
Phytomedicine; 2007 Sep; 14(9):587-90. PubMed ID: 17289362
[TBL] [Abstract][Full Text] [Related]
28. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content.
Modarai M; Gertsch J; Suter A; Heinrich M; Kortenkamp A
J Pharm Pharmacol; 2007 Apr; 59(4):567-73. PubMed ID: 17430641
[TBL] [Abstract][Full Text] [Related]
29. Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4).
Modarai M; Yang M; Suter A; Kortenkamp A; Heinrich M
Planta Med; 2010 Mar; 76(4):378-85. PubMed ID: 19790031
[TBL] [Abstract][Full Text] [Related]
30. Myrsine seguinii ethanolic extract and its active component quercetin inhibit macrophage activation and peritonitis induced by LPS by targeting to Syk/Src/IRAK-1.
Yang WS; Jeong D; Yi YS; Lee BH; Kim TW; Htwe KM; Kim YD; Yoon KD; Hong S; Lee WS; Cho JY
J Ethnopharmacol; 2014 Feb; 151(3):1165-1174. PubMed ID: 24378351
[TBL] [Abstract][Full Text] [Related]
31. A standardized extract of
Sudeep HV; Gouthamchandra K; Ramanaiah I; Raj A; Naveen P; Shyamprasad K
Pharm Biol; 2023 Dec; 61(1):1211-1221. PubMed ID: 37585723
[TBL] [Abstract][Full Text] [Related]
32. Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts.
Chicca A; Raduner S; Pellati F; Strompen T; Altmann KH; Schoop R; Gertsch J
Int Immunopharmacol; 2009 Jul; 9(7-8):850-8. PubMed ID: 19303464
[TBL] [Abstract][Full Text] [Related]
33. Echinacea species and alkamides inhibit prostaglandin E(2) production in RAW264.7 mouse macrophage cells.
LaLone CA; Hammer KD; Wu L; Bae J; Leyva N; Liu Y; Solco AK; Kraus GA; Murphy PA; Wurtele ES; Kim OK; Seo KI; Widrlechner MP; Birt DF
J Agric Food Chem; 2007 Sep; 55(18):7314-22. PubMed ID: 17696440
[TBL] [Abstract][Full Text] [Related]
34. Comparative metabolomics approach coupled with cell- and gene-based assays for species classification and anti-inflammatory bioactivity validation of Echinacea plants.
Hou CC; Chen CH; Yang NS; Chen YP; Lo CP; Wang SY; Tien YJ; Tsai PW; Shyur LF
J Nutr Biochem; 2010 Nov; 21(11):1045-59. PubMed ID: 20005088
[TBL] [Abstract][Full Text] [Related]
35. Echinacea purpurea (L.) Moench modulates human T-cell cytokine response.
Fonseca FN; Papanicolaou G; Lin H; Lau CB; Kennelly EJ; Cassileth BR; Cunningham-Rundles S
Int Immunopharmacol; 2014 Mar; 19(1):94-102. PubMed ID: 24434371
[TBL] [Abstract][Full Text] [Related]
36. Immunomodulatory effects of clove (Syzygium aromaticum) constituents on macrophages: in vitro evaluations of aqueous and ethanolic components.
Dibazar SP; Fateh S; Daneshmandi S
J Immunotoxicol; 2015; 12(2):124-31. PubMed ID: 24873744
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of innate and adaptive immune functions by multiple Echinacea species.
Zhai Z; Liu Y; Wu L; Senchina DS; Wurtele ES; Murphy PA; Kohut ML; Cunnick JE
J Med Food; 2007 Sep; 10(3):423-34. PubMed ID: 17887935
[TBL] [Abstract][Full Text] [Related]
38. Supercritical fluid extraction of alkylamides from Echinacea angustifolia.
Sun L; Rezaei KA; Temelli F; Ooraikul B
J Agric Food Chem; 2002 Jul; 50(14):3947-53. PubMed ID: 12083864
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxic effects of Echinacea purpurea flower extracts and cichoric acid on human colon cancer cells through induction of apoptosis.
Tsai YL; Chiu CC; Yi-Fu Chen J; Chan KC; Lin SD
J Ethnopharmacol; 2012 Oct; 143(3):914-9. PubMed ID: 22971663
[TBL] [Abstract][Full Text] [Related]
40. Total bacterial load within Echinacea purpurea, determined using a new PCR-based quantification method, is correlated with LPS levels and in vitro macrophage activity.
Pugh ND; Jackson CR; Pasco DS
Planta Med; 2013 Jan; 79(1):9-14. PubMed ID: 23212786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
